Craig Barker

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer

M. Ratcliffe, Alan Sharpe, Anita Midha et al. · Clinical Cancer Research · 2017 · 303 citations

Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer

Michel E. Vandenberghe, Marietta Scott, Paul W. Scorer et al. · Scientific Reports · 2017 · 202 citations · Full text

Breast Oncology, Engineering, Machine Learning +18

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

Nicola Lawson, Carly I. Dix, Paul W. Scorer et al. · Modern Pathology · 2019 · 85 citations · Full text

Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA

Helen Brown, Johan Vansteenkiste, Kazuhiko Nakagawa et al. · Journal of Thoracic Oncology · 2019 · 59 citations · Full text

Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis

Moritz Widmaier, Tobias Wiestler, Jill Walker et al. · Modern Pathology · 2019 · 57 citations · Full text

Engineering, Pathology, Tumor Biology +20